Physician

Scott Michael Anfinson, M.D.

According to 2025 Medicare claims, Scott Anfinson, M.D. (NPI: 1285678029) practices ophthalmology in the Hilton Head Island-Bluffton-Port Royal, SC market, with the plurality of this provider's patient population coming from Beaufort, SC. This provider's primary affiliated billing organization is CHARLESTON NEUROSCIENCES INSTITUTE (NPI: 1225094600; TIN: 202359956) and primary practice location at 29910-4883.

Anfinson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 881 traditional Medicare patients, billed 8,321 HCPCS/CPT codes, and received $1,504,978 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 547 prescription claims across 94 beneficiaries totaling $19,317 in drug costs, led by Timolol Maleate (Timolol Maleate). Open Payments data shows 3 records totaling $259. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have fallen sharply in recent years, from $51,838 to $19,317. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,399	9,993	$602,601
2016	1,378	9,524	$592,320
2017	1,372	9,690	$639,071
2018	1,396	10,435	$737,309
2019	1,357	10,209	$752,896
2020	1,224	8,252	$604,123
2021	1,123	7,545	$514,021
2022	1,025	7,169	$533,606
2023	1,011	8,133	$844,896
2024	881	8,321	$1,504,978

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	136	590	$51,838
2016	114	568	$44,078
2017	116	632	$52,778
2018	120	626	$56,541
2019	123	567	$56,320
2020	118	583	$43,086
2021	107	529	$48,091
2022	106	602	$41,679
2023	102	538	$26,964
2024	94	547	$19,317

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
J0178	Injection, aflibercept, 1 mg	132	1,726	$654
67028	Injection of drug into eye	157	1,015	$87
92012	Established patient problem focused exam of visual system	796	1,333	$59
92134	Imaging of retina	526	1,682	$29
92201	Extended exam of the back part of the eye with retinal drawing	190	199	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Timolol Maleate	Timolol Maleate	86	4,788	$2,707
Latanoprost	Latanoprost	301	13,988	$1,703
Prednisolone Acetate	Prednisolone Acetate	27	906	$1,256
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	28	1,947	$640
Dorzolamide Hcl	Dorzolamide Hcl	29	1,448	$416

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$259	Astellas Pharma US Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Scott Michael Anfinson, M.D.?

Tedicare shows public-source Medicare data for Scott Michael Anfinson, M.D. (NPI 1285678029), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Scott Michael Anfinson, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Scott Michael Anfinson, M.D.?

Scott Michael Anfinson, M.D. is linked to CHARLESTON NEUROSCIENCES INSTITUTE (billing NPI 1225094600) in the available physician profile data.

Does Scott Michael Anfinson, M.D. have Open Payments data?

Scott Michael Anfinson, M.D. has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.